Study finds headache drug could prevent overuse of acute migraine medications by Jen Brogan | Jul 3, 2024 | News | 0 Chronic migraine is a neurological condition estimated to affect up to 2.2% of people globally Read More
AbbVie reveals results from pivotal atogepant trial by John Pinching | Apr 21, 2023 | News | 0 Study has been focusing on atogepant for the prevention of episodic migraine attacks Read More
Allergan’s experimental migraine drug hits trial targets by Selina McKee | Jun 12, 2018 | News | 0 Allergan says its CGRP receptor antagonist atogepant has hit its primary target in a Phase IIb/III trial assessing its efficacy in preventing episodic migraine. Read More